Duloxetine Pellets Manufacturer & Supplier

Duloxetine Pellets Manufacturer & Supplier - pharmaceutical overview

Duloxetine Pellets – Precision-Crafted for Reliable SNRI Performance. Rraynex’s duloxetine pellets are formulated to deliver consistent serotonin-norepinephrine reuptake inhibition (SNRI) through advanced enteric protection and precision-engineered layering. Designed for stability, uniformity, and optimal bioavailability, these pellets ensure predictable release profiles in the intestinal tract—empowering manufacturers to build high-performance antidepressant and neuropathic pain formulations. Overview: Duloxetine hydrochloride is a dual-action antidepressant that modulates both serotonin and norepinephrine pathways to treat major depressive disorder, generalized anxiety disorder, and neuropathic pain. Our pelletised form enhances stability, reduces gastric degradation, and delivers reliable absorption—ideal for controlled-release capsule and tablet applications. Key Features & Benefits: • Controlled Release Design: Enteric coatings delay release until intestinal pH levels, ensuring gastric protection and steady absorption. • Uniform Pellet Density: Precision spheronisation and solvent layering guarantee consistent pellet morphology and low friability. • Real-Time Process Analytics: Continuous monitoring of moisture, assay, and coating thickness ensures batch-to-batch reproducibility. • High Purity & Low Impurities: Pharmacopeial-grade duloxetine hydrochloride processed under stringent GMP and PAT frameworks. • Versatile Applications: Compatible with capsule filling, multiparticulate tablets, or film-coated dosage forms. • Data-Driven Validation: Comparative dissolution, impurity profiles, and accelerated stability data across climatic zones included. Technical Specifications: • API: Duloxetine Hydrochloride • Assay: 98.0–102.0% • Pellet Size Range: 500–1000 μm (customizable) • Enteric Polymer: Methacrylic Acid Copolymers or HPMC-based systems • Loss on Drying: ≤1.5% • Packaging: 25 kg HDPE drum with inner liner or nitrogen-flushed bags for clinical batches • Storage: Store below 25°C, protected from moisture and direct sunlight. Applications: • Pharmaceutical manufacturers producing antidepressant or neuropathic pain formulations. • Contract development and manufacturing organizations (CDMOs) seeking SNRI pellet solutions. • R&D teams developing controlled-release or enteric-coated psychiatric formulations. Educational Insight: Duloxetine works by inhibiting the reuptake of serotonin and norepinephrine, enhancing neurotransmitter balance in the brain. Its enteric-protected pellet form prevents early degradation in gastric acid, allowing targeted release in the small intestine for improved therapeutic consistency and reduced side effects. Additional Information: duloxetine pellets, duloxetine hydrochloride pellets, SNRI pellets, antidepressant pellets, neuropathic pain pellets, enteric coated duloxetine, controlled release duloxetine, duloxetine API pellets, pharmaceutical pellets manufacturer, antidepressant raw material supplier Usage Note: For pharmaceutical manufacturing and educational reference only. End-use medications containing duloxetine should be used strictly under medical supervision. Manufacturers are advised to validate formulation performance according to pharmacopeial standards before commercialization.

Duloxetine Pellets Manufacturer & Supplier formulation considerations

• Controlled pelletization and coating for reproducible dissolution and downstream handling.
• Uniform particle size and morphology suitable for capsule filling and multiparticulate systems.
• Manufactured under WHO-GMP with in-process controls on assay, moisture and related substances.
• Technical support for formulation development, scale-up and regulatory documentation.

Technical specifications are available upon request.

Applications

• Capsule filling and multiparticulate dosage forms (including MUPS where applicable).
• Pharmaceutical formulation and commercial manufacturing for SNRI therapies.
• CDMO and contract manufacturing programs requiring bulk duloxetine pellets manufacturer & supplier.

Bulk pharmaceutical supply & commercial manufacture

Rraynex operates as a pharmaceutical pellets manufacturer and supplier based in India, supporting bulk supply, export and contract manufacturing for Duloxetine Pellets Manufacturer & Supplier. Supply is available in standard 25/50 kg packaging with batch traceability. Export documentation, DMF/COA access procedures and stability information are provided on request for applicable products.

Contact Rraynex for bulk pellet supply • View manufacturing capabilities

Bulk pharmaceutical supply & product enquiries

Looking to source Duloxetine Pellets Manufacturer & Supplier in bulk? Rraynex supports pharmaceutical companies seeking Duloxetine Pellets Manufacturer & Supplier for formulation development, capsule filling and commercial pharmaceutical manufacturing. Buyers can request product specifications, available strengths, technical documentation, samples where applicable, commercial quotations and bulk supply information.

• product specifications
• available strengths
• technical documentation
• samples where applicable
• commercial quotations
• bulk supply information

B2B supply only — not a consumer pharmacy. Pricing available on request for bulk quantities.

Related capabilities

• Pharmaceutical Pellets
• Enteric Coated Pellets
• Sustained Release Pellets
• Modified Release Pellets
• MUPS Pellets
• Contract Manufacturing & CDMO Services
• Contact Sales for Duloxetine Enquiry

Related products